{"id":1656,"date":"2026-05-30T21:09:14","date_gmt":"2026-05-30T21:09:14","guid":{"rendered":"https:\/\/one-peptides.com\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/"},"modified":"2026-10-03T13:01:28","modified_gmt":"2026-10-03T13:01:28","slug":"bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants","status":"publish","type":"post","link":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/","title":{"rendered":"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide"},"content":{"rendered":"<div class=\"op-breadcrumbs\" style=\"margin:0 0 18px;font-size:13px;color:#6b7280;\"><div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/one-peptides.com\/de\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/one-peptides.com\/de\/category\/regeneration\/\" title=\"Regeneration &amp; research peptides\">Regeneration &amp; research peptides<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tBPC-157 vs ARG BPC-157 \u2013 comparison of two variants of the research peptide\n<\/span><\/div><\/div>\n<p>In the Research Use Only reagent market, the term &#8220;BPC-157&#8221; covers several chemical variants &#8211; differing in salt form, quality of synthesis and sometimes peptide sequence. The abbreviation <strong>ARG BPC-157<\/strong> functions in suppliers&#8217; catalogs as a separate marking and can be a source of real confusion &#8211; because it does not always refer to the same compound. For a researcher evaluating two &#8220;BPC-157&#8221; reagents for the repeatability of an experimental protocol, the distinction between these variants is fundamental. The chemical identification in the certificate of analysis (COA) is the only reliable signal; a trade name alone is not sufficient.<\/p>\n<p>For the wider regeneration framework, see <a href=\"https:\/\/one-peptides.com\/de\/how-do-peptides-support-recovery-a-guide-for-biohackers\/\">how recovery peptides work<\/a>.<\/p>\n<p>This article compares classic BPC-157 (most often as an acetate salt) with variants described as &#8220;ARG BPC-157&#8221; &#8211; along five axes: chemical identity and nomenclature, solution stability and preservation, pharmacokinetics and route of administration, mechanistic profile in research models, regulatory status, and limitations of the evidence base. The idea is to give the reader the tools to evaluate each vial by COA, not to rank the &#8220;better&#8221; variant.<\/p>\n<blockquote>\n<p>\ud83d\udcd6 The following article is educational and is a review of published scientific literature. Most of the cited studies were conducted on animal models or in vitro. The text does not constitute medical advice. All One Peptides products in the freeze-dried peptides category are intended exclusively for laboratory tests (Research Use Only).<\/p>\n<\/blockquote>\n<h2>What exactly does &#8220;ARG BPC-157&#8221; mean?<\/h2>\n<p>The term &#8220;ARG BPC-157&#8221; functions in the trade of research peptides in two senses. For a reliable COA interpretation, you need to know which one you are dealing with.<\/p>\n<h3>Meaning one: arginine salt BPC-157 (arginate)<\/h3>\n<p>In this variant, the peptide sequence remains <strong>identical to the classic BPC-157<\/strong> (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, 15 amino acids). Only the <strong>salt form<\/strong> changes \u2014 i.e. the counterion with which the peptide is paired during synthesis and crystallization.<\/p>\n<p>The standard form of BPC-157 in circulation is <strong>acetate salt<\/strong> (BPC-157 acetate) or <strong>trifluoroacetate salt<\/strong> (BPC-157 TFA salt &#8211; typical after HPLC purification). Arginine salt is an alternative &#8211; the peptide is bound to an arginine residue acting as a pH buffer and solution stabilizer. The amino acid sequence of the peptide itself does not change; counterion is different.<\/p>\n<p>Marketing arguments for arginine salt in RUO supplier catalogs:<\/p>\n<ul>\n<li>Better solubility in bacteriostatic water<\/li>\n<li>More stable solution for 28 days after reconstitution<\/li>\n<li>Less residual TFA ions (which can be problematic in some protocols)<\/li>\n<li>Hypothetically, better oral bioavailability due to interaction with amino acid transporters<\/li>\n<\/ul>\n<p>These arguments are mechanistically coherent, but <strong>there is a lack of head-to-head peer-reviewed research<\/strong> directly comparing the bioavailability and stability of arginine vs. acetate salt of BPC-157 under experimental conditions.<\/p>\n<h3>Second meaning: variant with an added arginine residue in the sequence<\/h3>\n<p>In this (rare but real) sense, &#8220;ARG BPC-157&#8221; is a peptide with a <strong>modified sequence<\/strong> \u2014 with an arginine residue attached to the N-terminus or C-terminus of classic BPC-157. The sequence becomes e.g. <strong>Arg-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val<\/strong> (16 amino acids instead of 15).<\/p>\n<p>This is <strong>a structurally different peptide<\/strong>. The molecular mass is higher by ~156 Da (mass of the arginine residue with a guanidine group). The charge profile at physiological pH is different (Arg contributes a positive charge at the end of the peptide). The mechanistic implications of such a modification are only partially predictable &#8211; a positively charged Arg can influence binding to the anionic domains of proteins, the way they interact with cell membranes and the stability against proteases.<\/p>\n<h3>How to tell them apart in the COA<\/h3>\n<p>The certificate of analysis (COA) must include:<\/p>\n<ul>\n<li><strong>The complete amino acid sequence<\/strong> \u2014 this is a clear identification of the peptide<\/li>\n<li><strong>Theoretical and measured molecular mass<\/strong> \u2014 the difference between the classic BPC-157 (1419.53 Da) and the Arg-BPC-157 variant (1575.71 Da) is immediately visible<\/li>\n<li><strong>Salt form<\/strong> (acetate \/ TFA \/ arginate \/ chloride) &#8211; information about counterion<\/li>\n<li><strong>MS spectrum<\/strong> \u2014 the measured mass allows you to distinguish salt (different masses of buffer fragments) from sequence modifications (different mass of the main peak)<\/li>\n<\/ul>\n<p>In practice &#8211; if the COA shows a mass of ~1419 Da, you have classic BPC-157 in the form of any salt. If it shows ~1575 Da, you have a peptide with an Arg residue added in the sequence. These are two separate reagents.<\/p>\n<h2>Chemical identity comparison<\/h2>\n<table data-border-width=\"1\" style=\"min-width: 100px; border-collapse: collapse; border-spacing: 0px; width: 100%;\">\n<colgroup>\n<col style=\"min-width: 25px;\"\/>\n<col style=\"min-width: 25px;\"\/>\n<col style=\"min-width: 25px;\"\/>\n<col style=\"min-width: 25px;\"\/><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Characteristic<\/strong><\/th>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>BPC-157 (classic, acetate\/TFA)<\/strong><\/th>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>ARG BPC-157 (arginine salt)<\/strong><\/th>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>ARG BPC-157 (with added Arg in sequence)<\/strong><\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Sequence<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">15 aa (GEPPPGKPADDAGLV)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">15 aa (identical)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">16 aa (Arg-GEPPPGKPADDAGLV or C-Arg)<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Molecular mass of the peptide<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">1419.53 Da<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">1419.53 Da<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">~1575.71 Da<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Salt form (counterion)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Acetate or trifluoroacetate<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Arginine<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Acetate \/ TFA \/ arginate (variable)<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">HPLC reference purity<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">\u226598% (RUO standard)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">\u226598% (RUO standard)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">\u226598% (RUO standard)<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">MS Identity &#8211; Measured mass<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">~1419 Da<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">~1419 Da + arginine signal<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">~1575 Da<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Net charge at physiological pH<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Close to neutral<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Close to neutral<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Slightly positive (Arg)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Solution stability and preservation<\/h2>\n<p>Peptide stability covers two horizons: <strong>dry lyophilisate<\/strong> (storage before reconstitution) and <strong>solution after dissolution<\/strong>.<\/p>\n<h3>Dry lyophilisate<\/h3>\n<p>Classic BPC-157 in the form of lyophilisate is a relatively stable peptide thanks to four proline residues in the sequence (positions 3, 4, 5, 8). These residues introduce a rigid conformation that protects the peptide from proteolytic degradation and loss of structure. At storage conditions of 2\u20138\u00b0C, the lyophilisate remains active for <strong>up to 36 months<\/strong> from the date of synthesis.<\/p>\n<p>The arginine salt does not significantly affect the stability of the lyophilisate &#8211; in dry form, the peptide is stable regardless of the counterion. The difference may only be visible in solution.<\/p>\n<p>The variant with an added Arg residue in the sequence has theoretically similar lyophilized stability &#8211; the additional residue does not change the fundamental resistance of the prolines to proteolysis.<\/p>\n<h3>Reconstituted solution<\/h3>\n<p>After reconstitution in bacteriostatic water, the stability of the solution depends on three factors: solution pH, peptide concentration and storage temperature.<\/p>\n<ul>\n<li><strong>BPC-157 acetate\/TFA<\/strong> \u2014 typical solution stability 28\u201330 days at 2\u20138\u00b0C. A concentration of 1\u20132 mg\/mL maintains full activity. Freeze\/thaw cycles should be avoided.<\/li>\n<li><strong>BPC-157 arginate<\/strong> \u2014 marketing arguments indicate a longer period of solution stability thanks to the buffering properties of arginine. The hypothesis is mechanistically consistent (Arg stabilizes pH 6.5\u20137.5, optimal for most short peptides), but <strong>there is a lack of published head-to-head studies<\/strong> verifying a longer shelf life compared to the acetate salt.<\/li>\n<li><strong>Arg-BPC-157 (modified sequence)<\/strong> \u2014 no published data on solution stability. An additional residue at the end of the peptide may influence the susceptibility to endo- and exopeptidases present in the prepared solution, but the direction of the influence is not clear.<\/li>\n<\/ul>\n<p>All variants require identical storage conditions for the lyophilisate &#8211; tight container, 2-8\u00b0C, protection from light. The <a href=\"https:\/\/one-peptides.com\/de\/peptide-calculator\/\">peptide calculator<\/a> will help you calculate the appropriate volume of solvent for the planned working concentration.<\/p>\n<h2>Pharmacokinetics and routes of administration in models<\/h2>\n<p>Classic BPC-157 is one of the few research peptides with documented evidence of <strong>oral bioavailability<\/strong> in animal models. Four proline residues block the cleavage of the peptide by pepsin, which allows BPC-157 to pass through the stomach to further sections of the digestive tract in an active form (Sikiric 2018\u00b9).<\/p>\n<p>Three main routes of peptide administration are reported in experimental models:<\/p>\n<ul>\n<li><strong>Injection (subcutaneous, intraperitoneal)<\/strong> \u2014 best documented in Sikiric&#8217;s works<\/li>\n<li><strong>Oral (gavage in rodents)<\/strong> \u2014 documented for gastric and intestinal ulcers<\/li>\n<li><strong>Topical<\/strong> \u2014 a few studies on skin wounds<\/li>\n<\/ul>\n<p>As for the arginine salt variants and Arg-BPC-157 &#8211; documentation in the literature is incomplete:<\/p>\n<ul>\n<li><strong>BPC-157 arginate<\/strong> \u2014 the marketing argument of &#8220;better oral bioavailability&#8221; is based on the assumption that arginine can interact with the PEPT1\/PEPT2 amino acid transporters present in the intestinal epithelium, enhancing absorption. It&#8217;s mechanistically possible, but there are <strong>no peer-reviewed head-to-head trials<\/strong> comparing the oral bioavailability of arginine vs. acetate salt.<\/li>\n<li><strong>Arg-BPC-157 (sequence)<\/strong> \u2014 the additional positive charge of the N-terminus may influence the pharmacokinetic profile, but there are no published pharmacokinetic studies for this variant in any model.<\/li>\n<\/ul>\n<p>The pharmacokinetic profiles for classic BPC-157 are well described (Hsieh 2017\u00b2): the half-life in the serum of rat models after injection is approximately 2\u20134 hours, the peptide is widely distributed into tissues, and is mainly metabolized by the liver and kidneys. For arginine variants, data have not been published to the same extent of detail.<\/p>\n<h2>Mechanism of action &#8211; is the biological activity the same?<\/h2>\n<p>This question requires a distinction between two interpretations of &#8220;ARG BPC-157&#8221;:<\/p>\n<h3>Arginine salt &#8211; the same mechanism<\/h3>\n<p>If the peptide sequence is identical, <strong>the mechanism of action is the same<\/strong> as that of classic BPC-157. Counterion does not affect the way the peptide interacts with receptors and signaling pathways. Once dissolved in physiological solution, the salt dissociates and the peptide acts according to its mechanistic profiles.<\/p>\n<p>The BPC-157 mechanistic profile includes:<\/p>\n<ul>\n<li>Modulation of the nitric oxide axis (NO\/cGMP) and improvement of microcirculation<\/li>\n<li>Stimulation of angiogenesis by VEGF and FGF (Hsieh 2017\u00b2)<\/li>\n<li>Modulation of growth factors EGR-1, TGF-\u03b2, c-Met\/HGF<\/li>\n<li>Effect on the dopamine and serotonergic systems (DA\/5-HT modulation in the CNS)<\/li>\n<li>Anti-inflammatory effect by reducing TNF-\u03b1, IL-6, IL-1\u03b2<\/li>\n<\/ul>\n<p>These mechanisms are widely documented in the work of Sikiric and related groups (Chang 2014\u00b3, Cerovecki 2010\u2074). The arginine salt retains this full profile if the peptide sequence remains 15 amino acids long.<\/p>\n<h3>Variant with added Arg in the sequence &#8211; mechanism potentially changed<\/h3>\n<p>Adding an arginine residue to the N- or C-terminus of the peptide <strong>may modify the mechanistic profile<\/strong> in a way that is difficult to predict from the structure itself:<\/p>\n<ul>\n<li>Positively charged Arg can enhance interaction with the anionic domains of receptors and proteins<\/li>\n<li>Can change the recognition profile of proteases (both in terms of protection and new cleavage sites)<\/li>\n<li>It may affect transport across cell membranes and the blood-brain barrier<\/li>\n<\/ul>\n<p>With no published head-to-head studies comparing the biological activity of Arg-BPC-157 with classic BPC-157 in identical experimental models, <strong>inferring behavior or activity modification remains a hypothesis<\/strong>.<\/p>\n<p>This is an important methodological limitation for the researcher: if the experimental protocol aims to replicate literature results obtained with classic BPC-157, <strong>using the Arg-BPC-157 variant introduces an uncontrolled variable<\/strong>.<\/p>\n<h2>Regenerative profile in experimental models<\/h2>\n<p>The peer-reviewed body of work on classic BPC-157 includes over 100 experimental studies across tissue regeneration models:<\/p>\n<ul>\n<li>Tendons and ligaments (Cerovecki 2010\u2074, models of damage to the Achilles tendon and knee ligaments in the rat)<\/li>\n<li>Stomach and intestinal ulcers (Sikiric 2018\u00b9)<\/li>\n<li>Skeletal Muscles (Chang 2014\u00b3)<\/li>\n<li>Bone regeneration after a fracture<\/li>\n<li>Peripheral nerves<\/li>\n<li>Blood vessels and microcirculation<\/li>\n<\/ul>\n<p>For arginine variants:<\/p>\n<ul>\n<li><strong>BPC-157 arginate<\/strong> \u2014 if the peptide sequence is the same, the regenerative profile remains identical to the classic BPC-157 (no mechanistic grounds for expecting differences in biological effectiveness were found). Practical implications mainly concern the kinetics of peptide release from solution and potentially oral bioavailability.<\/li>\n<li><strong>Arg-BPC-157 (modified sequence)<\/strong> \u2014 no peer-reviewed output. All activity observations come from off-label reports from the biohacker community and have not been verified in controlled protocols.<\/li>\n<\/ul>\n<h2>What to realistically choose for a specific experiment<\/h2>\n<table data-border-width=\"1\" style=\"min-width: 50px; border-collapse: collapse; border-spacing: 0px; width: 100%;\">\n<colgroup>\n<col style=\"min-width: 25px;\"\/>\n<col style=\"min-width: 25px;\"\/><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Purpose of the experiment<\/strong><\/th>\n<th colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Reagent selection<\/strong><\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Replication of results from the literature (Sikiric, Chang, Cerovecki)<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Classic BPC-157 acetate or TFA<\/strong> \u2014 the same variant on which the original evidence base is based<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Experiment with emphasis on solution stability over a long time window<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>BPC-157 acetate<\/strong> \u2014 documented stability 28-30 days \/ optional <strong>arginate<\/strong> if an internal laboratory protocol verifies stability based on its own tests<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">A comparative experiment of both salt variants<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Classic BPC-157 + arginate<\/strong> in parallel groups with an identical protocol; <strong>requires independent COA verification for both variants<\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Sequence modification experiment &#8211; testing the effect of added Arg on activity<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Arg-BPC-157 (with Arg residue added)<\/strong> compared to classic BPC-157 as control; <strong>requires unambiguous identification in COA by molecular weight<\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\">Introduction of a new protocol with low risk of an uncontrolled variable<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border: 1px solid #d1d5db; padding: 8px 12px;\"><strong>Classic BPC-157 acetate\/TFA<\/strong> \u2014 the most documented variant in the literature<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Regulatory status and WADA<\/h2>\n<p>All BPC-157 variants\u2014regardless of salt form and minor sequence modifications\u2014remain <strong>research peptides (Research Use Only)<\/strong> in the European Union. None of the forms has been registered as a medicinal product by the EMA (European Medicines Agency). They are not classified as dietary supplements under EFSA.<\/p>\n<p>In some markets, <strong>BPC-157 in the form of oral capsules<\/strong> is sold as a dietary supplement under a separate registration \u2014 a different regulatory framework that One Peptides does not use. In our catalogue every form of BPC-157, capsules included, is a Research Use Only reagent.<\/p>\n<p>WADA status of classic BPC-157: the peptide is located on the <strong>WADA Prohibited List, category S0<\/strong> (non-approved substances), and it is prohibited at all times; athletes subject to anti-doping control must not use it. Arginine variants are not listed separately in WADA guidelines, but due to sequence identity (in the case of salt) or close relatedness (in the case of Arg-BPC-157) <strong>they should be treated analogously<\/strong>.<\/p>\n<h2>Frequently asked questions<\/h2>\n<div>\n<div>\n<h3>Is &#8220;ARG BPC-157&#8221; the same peptide as classic BPC-157?<\/h3>\n<div>\n<div>\n<p>It depends on interpretation. If the designation refers to the arginine salt of the classic BPC-157, the peptide sequence is identical &#8211; the difference lies only in the salt form (counterion). If the designation refers to a variant with an added arginine residue in the sequence (e.g. Arg-Gly-Glu-Pro\u2026), it is a structurally different peptide. Unambiguous identification is provided by COA &#8211; amino acid sequence, molecular mass (1419 Da vs ~1575 Da) and MS spectrum.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Does BPC-157 arginine salt have better oral bioavailability than acetate salt?<\/h3>\n<div>\n<div>\n<p>The mechanistic argument is based on the interaction of arginine with the amino acid transporters PEPT1\/PEPT2 in the intestinal epithelium. This is biochemically consistent, but there are no peer-reviewed head-to-head studies comparing the oral bioavailability of both variants in animal or human models. The inference remains a hypothesis.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Can I safely replace classic BPC-157 with arginine salt during an ongoing experiment?<\/h3>\n<div>\n<div>\n<p>From a purely mechanistic point of view, if the peptide sequence is identical (1419 Da, 15 amino acids), the biological activity should be the same. From the point of view of methodological rigor, changing the counterion during the experiment introduces a variable whose impact on the kinetics of peptide release in solution has not been verified head-to-head. For protocol repeatability, consistency in the choice of salt form is recommended.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>How can I tell that I got the classic BPC-157 and not the variant with an Arg residue added?<\/h3>\n<div>\n<div>\n<p>Check two fields in the COA: amino acid sequence (classic BPC-157: 15 aa, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) and major molecular mass in MS (classic: 1419 Da; variant with added Arg: ~1575 Da). The difference is immediately visible in the spectrum. If the COA does not contain this data, ask the supplier to provide it.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Does the stability of the lyophilisate depend on the form of salt?<\/h3>\n<div>\n<div>\n<p>In practice &#8211; no. Classic BPC-157 acetate, TFA salt and arginate in the form of lyophilisate show similar stability (up to 36 months at 2\u20138\u00b0C). Differences may become apparent in the solution after reconstitution &#8211; the arginine salt theoretically stabilizes pH better than the acetate salt, but the difference has not been documented in head-to-head studies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Does WADA treat BPC-157 arginine variants separately?<\/h3>\n<div>\n<div>\n<p>Classic BPC-157 is on the WADA Prohibited List, category S0. Arginine variants are not listed separately, but due to sequence identity (salt) or close relatedness (sequence modification), athletes subject to doping control should treat them analogously and verify current guidelines before use.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Is there a product that combines the advantages of both variants?<\/h3>\n<div>\n<div>\n<p>Supplier marketing sometimes suggests that &#8220;stable arginine salt with optional sequence modification&#8221; combines the benefits of both forms. From a researcher&#8217;s perspective, such products require special attention when verifying COA &#8211; it often turns out to be a variant with an added Arg residue in the sequence (1575 Da), advertised under a name suggesting identity with the classic BPC-157 (1419 Da). Identification by MS mass is the only reliable way to tell them apart.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2>Related content in the knowledge base<\/h2>\n<ul>\n<li><a href=\"https:\/\/one-peptides.com\/de\/bpc-157-what-it-is-mechanism-of-action-scientific-research\/\">BPC-157 \u2014 what it is, mechanism of action and research status<\/a><\/li>\n<li><a href=\"https:\/\/one-peptides.com\/de\/bpc-157-vs-tb-500-comparison-of-two-regenerative-peptides-in-research-context\/\">BPC-157 vs TB-500 &#8211; comparison of regenerative peptides<\/a><\/li>\n<li><a href=\"https:\/\/one-peptides.com\/de\/how-to-identify-high-quality-research-peptides-guide-to-analytical-and-purchasing-standards\/\">How to recognize high-quality research peptides<\/a><\/li>\n<li><a href=\"https:\/\/one-peptides.com\/de\/how-to-dissolve-peptides-a-step-by-step-guide\/\">How to dissolve peptides \u2013 a step-by-step guide<\/a><\/li>\n<li><a href=\"https:\/\/one-peptides.com\/de\/how-to-read-an-hplc-certificate-guide-for-researchers\/\">How to read an HPLC certificate<\/a><\/li>\n<li><a href=\"https:\/\/one-peptides.com\/de\/category\/regeneration\/\">regeneration category<\/a><\/li>\n<\/ul>\n<p>Classic BPC-157 available in the One Peptides catalog in the form of lyophilisate: BPC-157 10 mg. Each batch with HPLC certificate of analysis \u226598% and MS identity confirmation &#8211; sequence, molecular weight and salt form documented in <a href=\"https:\/\/one-peptides.com\/de\/quality-testing-and-certificates\/\">COA available to the public<\/a>. The full range of regenerative peptides is in the <a href=\"https:\/\/one-peptides.com\/de\/category-product\/bpc-157\/\">BPC-157 category<\/a> and, more broadly, in the <a href=\"https:\/\/one-peptides.com\/de\/category-product\/peptides\/\">research peptide categories<\/a>.<\/p>\n<h2>Bibliography<\/h2>\n<ol>\n<li>Sikiric P, Rucman R, Turkovic B, et al. (2018). <a href=\"https:\/\/doi.org\/10.2174\/1381612824666180608101119\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing<\/cite><\/a><\/li>\n<li>Hsieh MJ, Liu HT, Wang CN, et al. (2017). <a href=\"https:\/\/doi.org\/10.1007\/s00109-016-1488-y\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation<\/cite><\/a><\/li>\n<li>Chang CH, Tsai WC, Hsu YH, Pang JS (2014). <a href=\"https:\/\/doi.org\/10.3390\/molecules191119066\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts<\/cite><\/a><\/li>\n<li>Cerovecki T, Bojanic I, Brcic L, et al. (2010). <a href=\"https:\/\/doi.org\/10.1002\/jor.21107\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat<\/cite><\/a><\/li>\n<li>World Anti-Doping Agency (2024). <a href=\"https:\/\/www.wada-ama.org\/en\/prohibited-list\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>The 2024 prohibited list \u2014 international standard<\/cite><\/a><\/li>\n<li>Roberts M. J., Bentley M. D., Harris J. M. (2012). <a href=\"https:\/\/doi.org\/10.1016\/j.addr.2012.09.025\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>Chemistry for peptide and protein PEGylation<\/cite><\/a><\/li>\n<li>Mant CT, Chen Y, Yan Z, et al. (2007). <a href=\"https:\/\/doi.org\/10.1007\/978-1-59745-430-8_1\" rel=\"noopener noreferrer\" target=\"_blank\"><cite>HPLC analysis and purification of peptides<\/cite><\/a><\/li>\n<\/ol>\n<hr\/>\n<blockquote>\n<p>\u2139\ufe0f <strong>Disclaimer<\/strong><\/p>\n<p>All One Peptides products in the freeze-dried peptides category (including all BPC-157 variants) are chemical reagents intended exclusively for laboratory tests (Research Use Only). They are not medicinal products, dietary supplements or foodstuffs. The information in this article is educational in nature and is a review of published scientific literature; it does not constitute medical, pharmaceutical or dietary advice. BPC-157 is on the WADA Prohibited List, category S0 &#8211; athletes subject to doping control should verify current guidelines before use. <strong>BPC-157 in the form of oral capsules<\/strong> (<a href=\"https:\/\/one-peptides.com\/de\/produkt\/bpc-157-60-capsules-100mcg-bpc-157-100-mcg-bpc-arg\/\">see separate product card<\/a>) is also a Research Use Only reagent \u2014 only the packaging form differs.<\/p>\n<\/blockquote>\n<p><!-- onep-post-reviewer-banner:start --><\/p>\n<div class=\"author-box onep-post-reviewer-banner\" style=\"border-left: 4px solid #958e09; background: #f9fafb; padding: 16px 20px; margin: 32px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0; font-size: 14px; line-height: 1.5;\"><strong>Pharmaceutical review:<\/strong> <a href=\"https:\/\/one-peptides.com\/de\/team-aneta-kropicka\/\">MPharm Aneta Kropicka<\/a><br \/>\n<em>Pharmaceutical reviewer and sports supplementation expert.<\/em><br \/>\nMaster of Pharmacy with 12 years of professional experience, graduate of the Medical University of \u0141\u00f3d\u017a (2014). Verifies One Peptides content for pharmacology, clinical dosing, and regulatory compliance across RUO \/ dietary supplement \/ drug frameworks.<\/p>\n<p style=\"margin: 0; font-size: 12px; color: #6b7280;\"><small>Published: <time datetime=\"2026-05-30\">2026-05-30<\/time> \u2022 Last updated: <time datetime=\"2026-06-10\">2026-06-10<\/time><\/small><\/p>\n<\/div>\n<p><!-- onep-post-reviewer-banner:end --><\/p>","protected":false},"excerpt":{"rendered":"<p>In the Research Use Only reagent market, the term &#8220;BPC-157&#8221; covers several chemical variants &#8211; differing in salt form, quality of synthesis and sometimes peptide sequence. The abbreviation ARG BPC-157 functions in suppliers&#8217; catalogs as a separate marking and can be a source of real confusion &#8211; because it does not always refer to the same compound. For a researcher evaluating two &#8220;BPC-157&#8221; reagents for [\u2026]<\/p>\n","protected":false},"author":31,"featured_media":1652,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[149],"tags":[],"class_list":["post-1656","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regeneration"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Bartosz Bartczak\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"de_DE\" \/>\n\t\t<meta property=\"og:site_name\" content=\"One-Peptides -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides\" \/>\n\t\t<meta property=\"og:description\" content=\"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-30T21:09:14+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-03T13:01:28+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides\" \/>\n\t\t<meta name=\"twitter:description\" content=\"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#blogposting\",\"name\":\"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides\",\"headline\":\"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide\",\"author\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-bartosz-bartczak\\\/#person\"},\"publisher\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/bpc-vs-arg-bpc-157.webp\",\"width\":1536,\"height\":1024,\"caption\":\"bpc-157 iniecjtion vs arg bpc-157 in capsules\"},\"datePublished\":\"2026-05-30T21:09:14+00:00\",\"dateModified\":\"2026-10-03T13:01:28+00:00\",\"inLanguage\":\"de-DE\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#webpage\"},\"articleSection\":\"Regeneration &amp; research peptides\",\"wordCount\":2911,\"reviewedBy\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-aneta-kropicka\\\/#person\"}},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/category\\\/regeneration\\\/#listItem\",\"name\":\"Regeneration &amp; research peptides\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/category\\\/regeneration\\\/#listItem\",\"position\":2,\"name\":\"Regeneration &amp; research peptides\",\"item\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/category\\\/regeneration\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#listItem\",\"name\":\"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#listItem\",\"position\":3,\"name\":\"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/category\\\/regeneration\\\/#listItem\",\"name\":\"Regeneration &amp; research peptides\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#organization\",\"name\":\"One-Peptides\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/cropped-Image-1-e1751599136894.png\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#organizationLogo\",\"width\":291,\"height\":113},\"image\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#organizationLogo\"},\"legalName\":\"Joscur Limited\",\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/one_peptides\\\/\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"email\":\"contact@one-peptides.com\",\"contactType\":\"customer service\"},\"parentOrganization\":{\"@type\":\"Organization\",\"name\":\"Joscur Limited\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-bartosz-bartczak\\\/#person\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-bartosz-bartczak\\\/\",\"name\":\"Bartosz Bartczak\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18c5ebea790bc7a8bd4088066983b1a92e5db957aa4e5888766fe20b92c9cfe6?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Bartosz Bartczak\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-aneta-kropicka\\\/#person\",\"name\":\"Aneta Kropicka\",\"honorificPrefix\":\"M.Pharm.\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-aneta-kropicka\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#webpage\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/\",\"name\":\"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides\",\"description\":\"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.\",\"inLanguage\":\"de-DE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-bartosz-bartczak\\\/#person\"},\"creator\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/team-bartosz-bartczak\\\/#person\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/bpc-vs-arg-bpc-157.webp\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#mainImage\",\"width\":1536,\"height\":1024,\"caption\":\"bpc-157 iniecjtion vs arg bpc-157 in capsules\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\\\/#mainImage\"},\"datePublished\":\"2026-05-30T21:09:14+00:00\",\"dateModified\":\"2026-10-03T13:01:28+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/\",\"name\":\"One-Peptides\",\"inLanguage\":\"de-DE\",\"publisher\":{\"@id\":\"https:\\\/\\\/one-peptides.com\\\/de\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>BPC-157 vs ARG BPC-157 - comparison of regenerative peptides<\/title>\n\n","aioseo_head_json":{"title":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","description":"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.","canonical_url":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#blogposting","name":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","headline":"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide","author":{"@id":"https:\/\/one-peptides.com\/de\/team-bartosz-bartczak\/#person"},"publisher":{"@id":"https:\/\/one-peptides.com\/de\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp","width":1536,"height":1024,"caption":"bpc-157 iniecjtion vs arg bpc-157 in capsules"},"datePublished":"2026-05-30T21:09:14+00:00","dateModified":"2026-10-03T13:01:28+00:00","inLanguage":"de-DE","mainEntityOfPage":{"@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#webpage"},"isPartOf":{"@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#webpage"},"articleSection":"Regeneration &amp; research peptides","wordCount":2911,"reviewedBy":{"@id":"https:\/\/one-peptides.com\/de\/team-aneta-kropicka\/#person"}},{"@type":"BreadcrumbList","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/#listItem","position":1,"name":"Home","item":"https:\/\/one-peptides.com\/de\/","nextItem":{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/category\/regeneration\/#listItem","name":"Regeneration &amp; research peptides"}},{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/category\/regeneration\/#listItem","position":2,"name":"Regeneration &amp; research peptides","item":"https:\/\/one-peptides.com\/de\/category\/regeneration\/","nextItem":{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#listItem","name":"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide"},"previousItem":{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#listItem","position":3,"name":"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide","previousItem":{"@type":"ListItem","@id":"https:\/\/one-peptides.com\/de\/category\/regeneration\/#listItem","name":"Regeneration &amp; research peptides"}}]},{"@type":"Organization","@id":"https:\/\/one-peptides.com\/de\/#organization","name":"One-Peptides","url":"https:\/\/one-peptides.com\/de\/","logo":{"@type":"ImageObject","url":"https:\/\/one-peptides.com\/wp-content\/uploads\/2024\/09\/cropped-Image-1-e1751599136894.png","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#organizationLogo","width":291,"height":113},"image":{"@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#organizationLogo"},"legalName":"Joscur Limited","sameAs":["https:\/\/www.instagram.com\/one_peptides\/"],"contactPoint":{"@type":"ContactPoint","email":"contact@one-peptides.com","contactType":"customer service"},"parentOrganization":{"@type":"Organization","name":"Joscur Limited"}},{"@type":"Person","@id":"https:\/\/one-peptides.com\/de\/team-bartosz-bartczak\/#person","url":"https:\/\/one-peptides.com\/de\/team-bartosz-bartczak\/","name":"Bartosz Bartczak","image":{"@type":"ImageObject","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/18c5ebea790bc7a8bd4088066983b1a92e5db957aa4e5888766fe20b92c9cfe6?s=96&d=mm&r=g","width":96,"height":96,"caption":"Bartosz Bartczak"}},{"@type":"Person","@id":"https:\/\/one-peptides.com\/de\/team-aneta-kropicka\/#person","name":"Aneta Kropicka","honorificPrefix":"M.Pharm.","url":"https:\/\/one-peptides.com\/de\/team-aneta-kropicka\/"},{"@type":"WebPage","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#webpage","url":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/","name":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","description":"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.","inLanguage":"de-DE","isPartOf":{"@id":"https:\/\/one-peptides.com\/de\/#website"},"breadcrumb":{"@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#breadcrumblist"},"author":{"@id":"https:\/\/one-peptides.com\/de\/team-bartosz-bartczak\/#person"},"creator":{"@id":"https:\/\/one-peptides.com\/de\/team-bartosz-bartczak\/#person"},"image":{"@type":"ImageObject","url":"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp","@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#mainImage","width":1536,"height":1024,"caption":"bpc-157 iniecjtion vs arg bpc-157 in capsules"},"primaryImageOfPage":{"@id":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/#mainImage"},"datePublished":"2026-05-30T21:09:14+00:00","dateModified":"2026-10-03T13:01:28+00:00"},{"@type":"WebSite","@id":"https:\/\/one-peptides.com\/de\/#website","url":"https:\/\/one-peptides.com\/de\/","name":"One-Peptides","inLanguage":"de-DE","publisher":{"@id":"https:\/\/one-peptides.com\/de\/#organization"}}]},"og:locale":"de_DE","og:site_name":"One-Peptides -","og:type":"article","og:title":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","og:description":"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.","og:url":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/","og:image":"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp","og:image:secure_url":"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp","og:image:width":1536,"og:image:height":1024,"article:published_time":"2026-05-30T21:09:14+00:00","article:modified_time":"2026-10-03T13:01:28+00:00","twitter:card":"summary_large_image","twitter:title":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","twitter:description":"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.","twitter:image":"https:\/\/one-peptides.com\/wp-content\/uploads\/2026\/05\/bpc-vs-arg-bpc-157.webp"},"aioseo_meta_data":{"post_id":"1656","title":"BPC-157 vs ARG BPC-157 - comparison of regenerative peptides","description":"BPC-157 vs ARG BPC-157: difference between the arginine salt and the added Arg-residue variant. Chemical identity, stability and RUO status.","keywords":null,"keyphrases":{"focus":{"keyphrase":"bpc-157","score":73},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-10-03 13:02:35","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-05-31 07:58:33","updated":"2026-10-03 13:37:01","focus_keyword":"bpc-157","additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/one-peptides.com\/de\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/one-peptides.com\/de\/category\/regeneration\/\" title=\"Regeneration &amp; research peptides\">Regeneration &amp; research peptides<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tBPC-157 vs ARG BPC-157 \u2013 comparison of two variants of the research peptide\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/one-peptides.com\/de\/"},{"label":"Regeneration &amp; research peptides","link":"https:\/\/one-peptides.com\/de\/category\/regeneration\/"},{"label":"BPC-157 vs ARG BPC-157 &#8211; comparison of two variants of the research peptide","link":"https:\/\/one-peptides.com\/de\/bpc-157-vs-arg-bpc-157-comparison-of-two-research-peptide-variants\/"}],"_links":{"self":[{"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/posts\/1656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/comments?post=1656"}],"version-history":[{"count":18,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/posts\/1656\/revisions"}],"predecessor-version":[{"id":2838,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/posts\/1656\/revisions\/2838"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/media\/1652"}],"wp:attachment":[{"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/media?parent=1656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/categories?post=1656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/one-peptides.com\/de\/wp-json\/wp\/v2\/tags?post=1656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}